M118, a novel low-molecular weight heparin with decreased polydispersity leads to enhanced anticoagulant activity and thrombotic occlusion in ApoE knockout mice

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 4, 2009, Pages 394-400

  Chakrabarti, Subrata ^a   Beaulieu, Lea M ^a   Reyelt, Lara A ^b   Iafrati, Mark D ^b   Freedman, Jane E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Arterial thrombosis; Carotid artery; Heparin; LMWH; Neutrophil platelet conjugate; Rose Bengal laser induced model of arterial injury

Indexed keywords

APOLIPOPROTEIN E; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; M 118; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLEEDING TIME; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ANIMALS; ANTICOAGULANTS; APOLIPOPROTEINS E; DISEASE MODELS, ANIMAL; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; MALE; MICE; MICE, KNOCKOUT; THROMBOEMBOLISM; THROMBOSIS; TISSUE DISTRIBUTION;

EID: 70350536997     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0340-4     Document Type: Article

References (25)

1. Freedman JE (2005) Molecular regulation of platelet-dependent thrombosis. Circulation 112:2725-2734. doi: 10.1161/ CIRCULATIONAHA.104.494468
2. Bates SM, Weitz JI (2005) New anticoagulants: Beyond heparin, low-molecular-weight heparin and warfarin. Br J Pharmacol 144:1017-1028. doi: 10.1038/sj.bjp.0706153
3. Bates SM, Weitz JI (2005) Coagulation assays. Circulation 112:e53-e60. doi: 10.1161/CIRCULATIONAHA.104.478222
4. Gross PL, Weitz JI (2008) New anticoagulants for treatment of venous thromboembolism. Arterioscler Thromb Vasc Biol 28:380-386. doi: 10.1161/ ATVBAHA.108.162677
5. Rau JC, Beaulieu LM, Huntington JA et al (2007) Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 5:102-115. doi: 10.1111/ j.1538-7836.2007.02516.x
6. Jin L, Abrahams JP, Skinner R et al (1997) The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci USA 94:14683-14688. doi: 10.1073/pnas.94.26.14683
7. Shriver Z, Sundaram M, Venkataraman G et al (2000) Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin. Proc Natl Acad Sci USA 97:10365-10370. doi: 10.1073/pnas.97.19.10365
8. Petitou M, Imberty A, Duchaussoy P et al (2001) Experimental proof for the structure of a thrombin-inhibiting heparin molecule. Chemistry (Easton) 7:858-873
9. Sundaram M, Qi Y, Shriver Z et al (2003) Rational design of low-molecular weight heparins with improved in vivo activity. Proc Natl Acad Sci USA 100:651-656. doi: 10.1073/pnas.252643299
10. Naoum JJ, Woodside KJ, Zhang S et al (2005) Effects of rapamycin on the arterial inflammatory response in atherosclerotic plaques in Apo-E knockout mice. Transplant Proc 37:1880-1884. doi: 10.1016/ j.transproceed.2005.02.080
11. Naoum JJ, Zhang S, Woodside KJ et al (2004) Aortic eNOS expression and phosphorylation in Apo-E knockout mice: Differing effects of rapamycin and simvastatin. Surgery 136:323-328. doi: 10.1016/j.surg.2004.05.007
12. Wilson KM, Lynch CM, Faraci FM et al (2003) Effect of mechanical ventilation on carotid artery thrombosis induced by photochemical injury in mice. J Thromb Haemost 1:2669-2674. doi: 10.1111/ j.1538-7836.2003.00482.x
13. Vanichakarn P, Blair P, Wu C et al (2008) Neutrophil CD40 enhances platelet-mediated inflammation. Thromb Res 122:346-358. doi: 10.1016/ j.thromres.2007.12.019
14. Chakrabarti S, Varghese S, Vitseva O et al (2005) CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb Vasc Biol 25:2428-2434. doi: 10.1161/01.ATV.0000184765.59207.f3
15. Smyth SS, Reis ED, Vaananen H et al (2001) Variable protection of beta 3-integrin-deficient mice from thrombosis initiated by different mechanisms. Blood 98:1055-1062. doi: 10.1182/blood.V98.4.1055
16. Severin S, Gratacap MP, Lenain N et al (2007) Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth. J Clin Invest 117:944-952. doi: 10.1172/JCI29967
17. Brey EM, Lalani Z, Johnston C et al (2003) Automated selection of DAB-labeled tissue for immunohistochemical quantification. J Histochem Cytochem 51:575-584
18. Furman MI, Krueger LA, Linden MD et al (2005) GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention. J Thromb Haemost 3:312-320. doi: 10.1111/j.1538-7836.2005.01124.x
19. Furman MI, Kereiakes DJ, Krueger LA et al (2001) Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab. Am Heart J 142:790-798. doi: 10.1067/mhj.2001.119128
20. Furman MI, Barnard MR, Krueger LA et al (2001) Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38:1002-1006. doi: 10.1016/ S0735-1097(01)01485-1
21. Furman MI, Benoit SE, Barnard MR et al (1998) Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31:352-358. doi: 10.1016/S0735-1097(97)00510-X
22. Westrick RJ, Eitzman DT (2007) Plasminogen activator inhibitor-1 in vascular thrombosis. Curr Drug Targets 8:966-1002. doi: 10.2174/ 138945007781662328
23. Bates SM, Weitz JI (2000) The mechanism of action of thrombin inhibitors. J Invasive Cardiol 12:27-32
24. Gallus AS (2003) Preventing venous thromboembolism in general medical inpatients and after an ischaemic stroke. Haemostasis 30:64-71. doi: 10.1159/000054166
25. Michelson AD, Barnard MR, Krueger LA et al (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104:1533-1537. doi: 10.1161/hc3801.095588